Arka Banerjee

Arka Banerjee

Auto-generated profile, based on publicly available information

Arka Banerjee

Department of Microbiology and Immunology Weill Cornell Medical College New York New York USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2024 in Journal of Biological Chemistry
Verified
Journal Article
Open access
ABArka Banerjee
Arka Banerjee
MCMoubani Chakraborty
Moubani Chakraborty
SSSuruchi Sharma
Suruchi Sharma
RCRuchi Chaturvedi
Ruchi Chaturvedi
ABAvipsa Bose
Avipsa Bose
SVSandhya S. Visweswariah
Sandhya S. Visweswariah
Mycobacterial genomes encode multiple adenylyl cyclases and cAMP effector proteins, underscoring the diverse ways these bacteria utilize cAMP. We identified universal stress proteins, Rv1636 and MSMEG_3811 in Mycobacterium tuberculosis and Mycobacterium smegmatis, respectively, as abundantly expressed, novel cAMP-binding proteins. Rv1636 is secreted via the SecA2 secretion system in M. tuberculosis but is not directly responsible for the efflux of cAMP from the cell. In slow-growing mycobacteria, intrabacterial concentrations of Rv1636 were equivalent to the concentrations of cAMP present in the cell. In contrast, levels of intrabacterial MSMEG_3811 in M. smegmatis were lower than that of cAMP and therefore, overexpression of Rv1636 increased levels of "bound" cAMP. While msmeg_3811 could be readily deleted from the genome of M. smegmatis, we found that the rv1636 gene is essential for the viability of M. tuberculosis and is dependent on the cAMP-binding ability of Rv1636. Therefore, Rv1636 may function to regulate cAMP signaling by direct sequestration of the second messenger. This is the first evidence of a "sponge" for any second messenger in bacterial signaling that would allow mycobacterial cells to regulate the available intrabacterial "free" pool of cAMP.

23 January 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
ABArka Banerjee
Arka Banerjee
MCMoubani Chakraborty
Moubani Chakraborty
SSSuruchi Sharma
Suruchi Sharma
RCRuchi Chaturvedi
Ruchi Chaturvedi
ABAvipsa Bose
Avipsa Bose
SVSandhya S. Visweswariah
Sandhya S. Visweswariah
Mycobacterium tuberculosis employs several signaling pathways to regulate its cellular physiology and survival within the host. Mycobacterial genomes encode multiple adenylyl cyclases and cAMP effector proteins, underscoring the diverse ways in which these bacteria utilize cAMP. We have earlier identified universal stress proteins (USP), Rv1636 and MSMEG_3811 in M. tuberculosis and M. smegmatis respectively, as abundantly expressed, novel cAMP-binding proteins. In this study, we show that these USPs may function to regulate cAMP signaling by direct sequestration of the second messenger. In slow-growing mycobacteria, concentrations of Rv1636 were equivalent to the amounts of cAMP present in the cell, and overexpression of Rv1636 in M. smegmatis increased levels of ‘bound’ cAMP. Rv1636 is secreted via the SecA2 secretion system in M. tuberculosis but is not directly responsible for the efflux of cAMP from the cell. While msmeg_3811 could be readily deleted from the genome of M. smegmatis , we find that the rv1636 gene is essential for growth of M. tuberculosis , and this functionality depends on the cAMP-binding ability of Rv1636. This is the first evidence of a ‘sink’ for any second messenger in bacterial signaling that would allow mycobacterial cells to regulate the available intracellular ‘free’ pool of cAMP.

10 August 2026 in Advanced Science
Verified
Journal Article
Open access
FFFranziska Fries
Franziska Fries
JHJennifer Herrmann
Jennifer Herrmann
MMMichael Dal Molin
Michael Dal Molin
YWYaëlle Wormser
Yaëlle Wormser
TRTimo Risch
Timo Risch
SPStéphanie Petrella
Stéphanie Petrella
Despite significant advancements in drug development and discovery, tuberculosis remains one of the world's deadliest infectious diseases. The rise and global spread of multidrug‐resistant strains underscore a critical need for new antibiotics with distinct mechanisms of action. Screening of a myxobacterial extract library uncovered the previously unrecognized antitubercular activity of corramycin, a natural product with potent bactericidal activity against both drug‐sensitive and ‐resistant Mycobacterium tuberculosis . Corramycin enters the bacterial cell by exploiting multiple transport systems, and induces DNA double‐strand breaks through a novel form of DNA gyrase poisoning. The cryo‐electron microscopy structure of M. tuberculosis gyrase in complex with corramycin reveals that the natural product targets a site overlapping with the binding site of synthetic fluoroquinolones, thereby locking the gyrase in an inactive conformation and preventing re‐ligation of DNA. Importantly, its unique mode of binding allows corramycin to overcome fluoroquinolone resistance, highlighting its promise as a novel antibiotic scaffold to address the antimicrobial resistance crisis.